Galmed Pharmaceuticals Ltd. (GLMD) NASDAQ
0.69
-0.0361(-4.96%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.24M |
| Enterprise Value | -749,352 |
| P/E Ratio | -0.44 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.29 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.02 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.55 |
| Return On Equity | -0.57 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -8.51M |
| Net Income | -10.31M |
| Diluted EPS | -2.39 |
Balance Sheet
| Total Cash | 18.16M |
| Total Cash/Share | 2.76 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.55 |
| Book Value Per Share | 2.4 |
Price History
| 52-Week Change | -53.3 |
| 52-Week High | 2.34 |
| 52-Week Low | 0.41 |
| Moving Average 50 Days | 0.62 |
| Moving Average 200 Days | 0.94 |
Statistics
| Average Volume | 3.01M |
| Shares Outstanding | 5.48M |
| % Held by Institutions | 122.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | August 30, 2024 |
